These data support our findings in experimental BPD, in which aberrant alveolar development was associated with low TMEM100 expression at the mRNA level and by immunohistochemical detection, which is a semi-quantitative measure for protein expression. Here, TMEM100 is linked to bronchopulmonary dysplasia.